SutroVax Announces $85M Series C Financing led by TPG Growth

Provides growth capital to advance pneumococcal vaccine to clinic and beyond Preeminent executive vaccinologist, Moncef Slaoui, appointed Board Chairman Strategic alignment established with Lonza Pharma & Biotech to create end-to-end supply chain ... Biopharmaceuticals, Venture Capital, Personnel SutroVax, pneumococcal vaccine, vaccine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news